OncoCyte Corp CEO Ronald Andrews receives $2.1M in 2019
OncoCyte Corp reports 2019 executive compensation
By ExecPay News
Published: May 26, 2020
OncoCyte Corp reported fiscal year 2019 executive compensation information on May 26, 2020.
In 2019, four executives at OncoCyte Corp received on average a compensation package of $1.5M, a 72% increase compared to previous year.
Ronald Andrews, Chief Executive Officer, received $2.1M in total. 78.73% of Andrews' compensation, or $1.6M, was in option awards. Andrews also received $276.3K in salary and $163.2K in stock awards.
William Annett, Chief Executive Officer, received a compensation package of $1.6M, which increased by 76% compared to previous year. 58.66% of the compensation package, or $955.5K, was in option awards.
Lyndal K. Hesterberg, Chief Scientific Officer, earned $1.2M in 2019, a 43% increase compared to previous year.
Mitchell Levine, Chief Financial Officer, received $1.2M in 2019, which increases by 33% compared to 2018.